Innate Pharma shares owned by Morgan Stanley
Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Innate Pharma
Tip: Access up to 7 years of quarterly data
All positions including Innate Pharma held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Innate Pharma by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $93k | 51k | 1.82 |
| 2024-12-31 | $80k | 44k | 1.84 |
| 2024-09-30 | $100k | 44k | 2.29 |
| 2024-06-30 | $84k | 44k | 1.94 |
| 2024-03-31 | $127k | 44k | 2.88 |
| 2023-12-31 | $130k | 46k | 2.80 |
| 2023-09-30 | $114k | 45k | 2.53 |
| 2023-06-30 | $145k | 47k | 3.08 |
| 2022-12-31 | $184k | 49k | 3.73 |
| 2022-06-30 | $126k | 47k | 2.70 |
| 2022-03-31 | $151k | 45k | 3.36 |
| 2021-06-30 | $121k | 37k | 3.30 |
| 2020-12-31 | $21k | 5.1k | 4.09 |
| 2020-09-30 | $6.0k | 1.6k | 3.82 |
| 2020-06-30 | $85k | 12k | 6.86 |
| 2020-03-31 | $22k | 3.3k | 6.67 |